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Abstract
Patent foramen ovale (PFO) is associated with high prevalence of stroke and systemic
embolisation. A 53-year-old man had mitral valve thrombus and PFO diagnosed by
echocardiography, in addition to carotid artery stenosis and embolic events including transient
ischemia attack, retinal artery occlusion and left kidney infarct. Surgical removal of the mitral
valve thrombus and concomitant coronary artery bypass were performed under cardiopulmo-
nary bypass. We believe this is the sole reported case of mitral valve thrombus associated with
a PFO. Due to their embolic potential, concomitant PFOs should be closed during heart
operations, and independent ones deserve interventional management in high-risk patients.
(Cardiol J 2008; 15: 467–470)
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Introduction
Patent foramen ovale (PFO) is a hemodynami-
cally insignificant interatrial communication, detec-
ted in 20–35% of autopsies and in 10–26% of living
individuals by contrast transesophageal echocardio-
graphy [1]. Omniplane transducers of transesopha-
geal echocardiography permit direct visualization of
the separation of the septum primum and septum
secondum [1]. Studies have revealed PFO might be
associated with stroke and systemic embolisation [2].
A high PFO prevalence has been noted in the stro-
ke population [3]. In the present case, PFO was
a causative factor responsible for the embolic events
and for mitral valve thrombus formation.
Case report
A 53-year-old man complained of lumbago on
the left for 2 weeks, and was diagnosed as a left
kidney infarct in the local hospital on 18 December
2007. He was afebrile. Echocardiography as part of
screening for a cardiac source of embolism demon-
strated a moderate sized (13 mm in diameter) ve-
getation attached to the posterior mitral valve le-
aflet, and a right-to-left shunting at the atrial level
was revealed by Doppler and agitated saline con-
trast, suggestive of a mitral valve myxoma and PFO.
There was no evidence of left atrial or left appen-
dage thrombus, atrial arrhythmia, infective endocar-
ditis or aortic arch atheroma. He was thus trans-
ferred to our hospital for surgical treatment on the
same day. He presented significant diabetes melli-
tus type 2, hypertension, hyperlipidemia and oste-
oporosis. About 2 years earlier at the end of Febru-
ary 2006, he developed transient ischemia attack on
the left, manifesting with transient left eye blind-
ness, which cleared up after a few hours. He was
referred to the local hospital and was diagnosed with
carotid artery stenosis and central retina artery
occlusion. On the second day he was managed with
carotid artery stenting.
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On admission, his temperature was 37.4°C,
pulse 88/min, respiration 18/min and blood pressu-
re 154/91 mm Hg. An apical systolic murmur of
grade 2/6 was audible. Laboratory tests showed
a normal blood count and normal hematological para-
meters. His blood sedimentation rate was 78 mm/hour
(normal: 0–20 mm/h). His electrocardiogram was nor-
mal. Routine catheterization showed the marginal
branch and right coronary artery severely stenosed.
An operation was performed on the same day
when he was referred to this hospital. Intraopera-
tive transesophageal echocardiography showed
a mobile, highly friable, cotton wadding-like vege-
tation measuring 1.39 × 1.09 cm, of a changeable
form with cardiac circle, attached to the atrial aspect
of the posterior mitral valve leaflet, with trivial
mitral valve regurgitation. There was no intracar-
diac thrombus, mitral valve prolapse or mitral an-
nulus calcification. Foreman ovale was patent exten-
ding 1.1 cm in diameter, with a maximal rightward
movement of 1.1 cm (Fig. 1A–1C).
The operation was carried out under standard
cardiopulmonary bypass. Coronary artery bypass
was performed with an in situ semi-skeletonized
left internal mammary artery bypassed to the mar-
ginal branch, and a saphenous vein graft to the ri-
ght coronary artery. A left atriotomy was made, and
a dark brown, opaque, dense, non-gelatinous, multi-
lobulated, multifronded vegetation 1.4 × 1.1 × 0.8 cm
in size was noted to be originated with a broad base
from the atrial aspect of the P2 portion of the mitral
valve leaflet near the edge of the cusp. The vegeta-
tion was removed without damaging the function
of the mitral valve leaflet. Careful inspection of in-
tracardiac cavities revealed no additional mass le-
sions. No evidence of mitral regurgitation was no-
ted by saline injection test. The foramen ovale was
patent 4 mm in diameter under direct vision, which
was closed by direct suture. Postbypass transeso-
phageal echocardiography illustrated a clear poste-
rior mitral leaflet, and a completely closed foramen
ovale (Fig. 1D).
Figure 1. Intraoperative transesophageal echocardiography showed (A) a mobile, highly friable vegetation measu-
ring 1.39 × 1.09 cm attached to the atrial aspect of the posterior mitral valve leaflet, (B) prolapsed into the left
ventricle during diastole, (C) patent foramen ovale (PFO) extending 1.1 cm in diameter, with a maximal movement of
1.1 cm, and (D) a clear mitral valve of post-bypass.
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His postoperative serum creatinine (23 De-
cember 2007) was 1.68 mg/dL. He was doing well
and was discharged on the 6th postoperative day. His
serum creatinine was normal at 4-week follow-up.
The gross sample from the posterior leaflet of
the mitral valve measured 1 × 0.8 × 0.8 cm in size.
Microscopic inspection revealed fragments of fibri-
nous material and small areas of fibromyxoid tissue.
Discussion
The PFOs with ≥ 2 mm separation of the sep-
tum primum and secondum were defined as large [4].
Morphologic studies on PFO showed that its size
averaged 4.9 (range, 1–19) mm, which was consi-
dered large enough for emboli to pass through and
to occlude the cerebral artery [2].
The mechanisms of the occurrence of stroke
in the PFO population remain unclear. A stagnant
flow might occur with PFO, and it might be suscep-
tible to atrial arrhythmias with possible intra-atrial
thrombus formation [5]. A more severe right-to-left
shunt and large opening of the PFO have been iden-
tified as the main characteristics in stroke patients
with paradoxical embolism. Right-to-left shunt at
rest without evidence of significant right atrial pres-
sure was a marker of risk for cerebral ischemia in
patients with PFO who might have increased expo-
sure to paradoxical emboli [2]. A multicenter per-
spective study showed that patients with larger
PFOs were associated with cryptogenic stroke and
high prevalence of deep venous thrombus [4].
Irrespective of antiphospholipid syndrome,
mitral valve thrombi might be formed in the pre-
sence of mitral valve calcification, mitral valve pro-
lapse, atrial fibrillation or infective endocarditis. Of
these, mitral valve calcification may serve as a ni-
dus for thrombus formation, leading to embolic stro-
ke [6]. Mitral valve prolapse might have an impact
on coagulation with increased thrombin generation
instead of on systemic platelet activation [7]. The
role that platelet coagulant hyperactivity played in
the pathogenesis of thromboembolism in patients
with mitral valve regurgitation has been drawn as
a conclusion by some authors [8].
Hashimoto et al. [9] reported one case of mi-
tral valve thrombus in a patient with intact mitral
valve, and the etiology was unclear. In comparison,
the present patient had a large PFO, which was as-
sociated with the embolic events of cerebral, retinal
and renal arteries, and was responsible for the forma-
tion of the valvular thrombus as well. Tice et al. [10]
defined mitral valve strands as thin (< 1 mm in
width), highly mobile, filamentous projections atta-
ched to the atrial surface of the mitral leaflets. The
vegetation of this patient outranged the concept of
a mitral valve strand, and hence was diagnosed as
a thrombus formation. Moreover, the differentiation
diagnosis from myxoma lay in a non-nebulous na-
ture shown on echocardiography, a non-gelatinous
appearance on the gross sample, and an eventual
fibrinous change confirmed by histological exami-
nation.
Emboli from within the heart are recognized
as a source of stroke, especially in young patients.
There was an 11% overall incidence of an associa-
ted intracardiac mass presumed to be responsible
for the neurological symptoms [11]. Intracardiac
thrombi are usually larger than 2 cm [12]. The
thrombus may be denser than the adjacent myocar-
dium with an akinetic or aneurysmal segment of
myocardium on echocardiography. Vegetation, tu-
mour or calcified deposit on a cardiac valve should
be considered in differential diagnosis as they usu-
ally share constitutional presentations such as fe-
ver, weight loss, and fatigue, etc. with an increased
sedimentation rate, and may lead to mitral valve re-
gurgitation and require surgical intervention. The
location, size, origin, shape and motion of the mass
were important in determining the nature of the
lesion [11].
Multiple transient ischemic attacks and stroke
can be the result of a cardiac tumour, most commonly
papillary fibroelastomas. The majority of these
common valve tumours morphologically resemble
a sea anemone with multiple papillary fronds [13],
usually originating from the mid portion of the va-
lve, smaller than 1 cm in diameter and pedicled by
a stalk with high mobility through the cardiac circ-
le [14]. Mitral valve myxomas may occur on the an-
terior or posterior mitral leaflet or the mitral annu-
lus, and can lead to embolisation, transient ische-
mic attack and stroke, caused by the tumour
fragments or thrombotic material on the myxoma
of the mitral leaflet [15]. Embolic events are frequ-
ent, life-threatening complications of infective en-
docarditis, accounting for 26% of the patient popu-
lation [16, 17]. Both the size and mobility of the
vegetations were related to the incidence of embo-
lic events. Patients with vegetations > 10 mm had
a 60% incidence of emboli. Patients with severely
mobile vegetations > 15 mm had an 83% incidence
and were at greatest risk [18].
Carotid artery stenosis may be associated with
other arterial lesions such as coronary and periphe-
ral arterial disease, and other vascular risk factors
such as hypertension, diabetes mellitus, hyperlipi-
demia and smoking [19]. In selected asymptomatic
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patients referred for percutaneous PFO closure,
incidental coronary angiography disclosed a preva-
lence of 29% clinically unsuspected coronary arte-
ry disease, with 9% ≥ 50% diameter stenoses,
5% one-vessel, 2% two-vessel and 2% three-ves-
sel disease [20]. The role of carotid artery stenosis
in the pathogenesis of ischemic stroke has been
known for centuries. The growth of the plaques and
the subsequent disintegration and ulceration might
be an explanation for ischemic stroke [19].
In the present patient, PFO and/or carotid ar-
tery stenosis might predispose stroke and syste-
mic embolic events. Meanwhile, it cannot be com-
pletely excluded that stroke was a sequela of coro-
nary artery disease or the mitral valve thrombus
itself. However, PFO and carotid artery stenosis
were alternatively the favoured causative patholo-
gies of the thrombus formation, with the former
being a possible predisposing factor of the embolic
events on the left side. This is the unique reported
case of a mitral valve thrombus associated with
a PFO.
Due to their embolic potential, concomitant
PFOs should be closed during heart operations,
and independent ones deserve interventional tre-
atment in high risk patients. Carotid artery steno-
sis ought to be surgically or interventionally ma-
naged as well.
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